IDEXX Laboratories, Inc. (VIE:IDXX)
Austria · Delayed Price · Currency is EUR 536.40
+2.20 (0.41%)
At close: Feb 3, 2026
IDEXX Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,059 | 887.87 | 845.04 | 679.09 | 744.85 |
Depreciation & Amortization | - | 129.94 | 114.91 | 111.9 | 104.6 |
Asset Writedown & Restructuring Costs | - | 0.25 | 1.48 | 2.35 | 5.15 |
Stock-Based Compensation | - | 60.3 | 59.74 | 49.77 | 37.76 |
Provision & Write-off of Bad Debts | - | 6.87 | 5.55 | 5.83 | 1.48 |
Other Operating Activities | 349.86 | -22.98 | -47.79 | -32.42 | -0.76 |
Change in Accounts Receivable | - | -28.28 | -53.87 | -41.4 | -33.14 |
Change in Inventory | - | -28 | -28.65 | -121.73 | -52.92 |
Change in Accounts Payable | - | 8.09 | -0.56 | 3.47 | 11.23 |
Change in Unearned Revenue | - | -4.38 | -3.03 | -11.02 | -7.55 |
Change in Other Net Operating Assets | -227.51 | -80.67 | 13.68 | -102.85 | -55.15 |
Operating Cash Flow | 1,182 | 929 | 906.51 | 542.98 | 755.55 |
Operating Cash Flow Growth | 27.21% | 2.48% | 66.95% | -28.13% | 16.59% |
Capital Expenditures | -124.68 | -120.92 | -133.63 | -148.84 | -119.55 |
Cash Acquisitions | -14.31 | -76.69 | - | -11.51 | -173.42 |
Sale (Purchase) of Intangibles | - | -10 | - | -10 | - |
Investment in Securities | - | -1 | - | -25 | - |
Other Investing Activities | 2.74 | 1.56 | 8.38 | - | - |
Investing Cash Flow | -136.24 | -207.06 | -125.25 | -195.35 | -292.97 |
Short-Term Debt Issued | 148 | - | - | 505.5 | 73.5 |
Total Debt Issued | 148 | - | - | 505.5 | 73.5 |
Short-Term Debt Repaid | - | - | -329 | - | - |
Long-Term Debt Repaid | -178.39 | -75 | -75 | -75 | -50 |
Total Debt Repaid | -178.39 | -75 | -404 | -75 | -50 |
Net Debt Issued (Repaid) | -30.39 | -75 | -404 | 430.5 | 23.5 |
Issuance of Common Stock | 93.36 | 44.49 | 47.03 | 35.75 | 46.57 |
Repurchase of Common Stock | -1,224 | -847.57 | -81.9 | -830.32 | -762.34 |
Other Financing Activities | -3.74 | - | -3.14 | -6.87 | -5.14 |
Financing Cash Flow | -1,165 | -878.07 | -442 | -370.94 | -697.41 |
Foreign Exchange Rate Adjustments | 11.2 | -9.53 | 2.13 | -8.61 | -4.64 |
Net Cash Flow | -108.2 | -165.67 | 341.39 | -31.91 | -239.47 |
Free Cash Flow | 1,057 | 808.08 | 772.88 | 394.15 | 636 |
Free Cash Flow Growth | 30.82% | 4.55% | 96.09% | -38.03% | 17.54% |
Free Cash Flow Margin | 24.56% | 20.73% | 21.11% | 11.71% | 19.78% |
Free Cash Flow Per Share | 13.05 | 9.71 | 9.20 | 4.66 | 7.35 |
Cash Interest Paid | - | 33.8 | 41 | 40.3 | 30.5 |
Cash Income Tax Paid | - | 307.2 | 192.5 | 239.8 | 161.7 |
Levered Free Cash Flow | 628.05 | 734.99 | 693.69 | 328.16 | 534.41 |
Unlevered Free Cash Flow | 650.45 | 754.49 | 719.68 | 353.07 | 553.04 |
Change in Working Capital | -227.51 | -133.24 | -72.43 | -273.53 | -137.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.